| 乳腺癌肿瘤浸润性淋巴细胞水平的影像评估进展 |
| |
| 引用本文： | 王梦意,胡仰玲,张小玲. 乳腺癌肿瘤浸润性淋巴细胞水平的影像评估进展[J]. 国际医学放射学杂志, 2022, 45(2): 180-183. DOI: 10.19300/j.2022.Z19481 |
| |
| 作者姓名： | 王梦意 胡仰玲 张小玲 |
| |
| 作者单位： | 中山大学附属第一医院放射科,广州 510080 |
| |
| 摘 要： | 肿瘤浸润性淋巴细胞（TIL）是肿瘤免疫中最受关注的生物标志物,TIL对乳腺癌新辅助化疗和免疫治疗有协同作用,可改善临床疗效。目前采用的评估TIL的方法不能全面反映TIL在肿瘤组织中分布的时间和空间异质性,而影像学具有无创、简便和整体性的特点,被预期为评估乳腺癌TIL水平的有效方法。就乳腺MRI、超声以及PET/CT和PET/MRI等影像学方法评估乳腺癌TIL水平的研究进展予以综述。
|
| 关 键 词： | 乳腺癌 肿瘤浸润性淋巴细胞 磁共振成像 正电子发射体层成像 体层摄影术 X线计算机 超声 |
| 收稿时间： | 2021-10-28 |
Advances in imaging evaluation of tumor-infiltrating lymphocytes in breast cancer |
| |
| WANG Mengyi,HU Yangling,ZHANG Xiaoling. Advances in imaging evaluation of tumor-infiltrating lymphocytes in breast cancer[J]. International Journal of Medical Radiology, 2022, 45(2): 180-183. DOI: 10.19300/j.2022.Z19481 |
| |
| Authors: | WANG Mengyi HU Yangling ZHANG Xiaoling |
| |
| Affiliation: | Department of Radiology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China |
| |
| Abstract: | Tumor-infiltrating lymphocytes (TIL) are emerging as the most concerned biomarker in tumor immunity. TIL can synergize with neoadjuvant chemotherapy and immunotherapy in breast cancer to enhance the efficacy of anticancer therapies. The methods used today can’t reflect the spatial and temporal heterogeneity of TIL in tumor tissue comprehensively, and imaging is expected as an effective method to evaluate TIL level in breast cancer due to its noninvasiveness, convenience and integrity. In this article, we reviewed the latest advances in the evaluation of TIL of breast cancer by imaging methods including breast magnetic resonance imaging, ultrasound, and 18F-FDG-PET-CT/MRI. |
| |
| Keywords: | Breast cancer Tumor-infiltrating lymphocytes Magnetic resonance imaging Positron emission tomography Tomography X-ray computed Ultrasonography |
| 本文献已被 万方数据 等数据库收录！ |
| 点击此处可从《国际医学放射学杂志》浏览原始摘要信息 |
|
点击此处可从《国际医学放射学杂志》下载全文 |
